Business Context and Reporting Period
This Form 8-K is a current report filed by iSpecimen Inc. on July 7, 2023. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol ISPC. The registrant is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The material event reported is the departure of a director:
- Christopher Ianelli resigned from the Board of Directors.
- The resignation was effective immediately upon receipt of the letter on July 7, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies related to the company's operations or financial condition.
Investor Verification Checklist
- Verify the effective date of Christopher Ianelli's resignation (July 7, 2023).
- Confirm whether the Board has appointed a replacement director to fill the vacancy.
- Review the company's most recent 10-Q or 10-K for current financial metrics, as this 8-K does not contain them.